CY1107298T1 - Υδατοδιαλυτα κοκκια μελοξικαμης - Google Patents

Υδατοδιαλυτα κοκκια μελοξικαμης

Info

Publication number
CY1107298T1
CY1107298T1 CY20081100265T CY081100265T CY1107298T1 CY 1107298 T1 CY1107298 T1 CY 1107298T1 CY 20081100265 T CY20081100265 T CY 20081100265T CY 081100265 T CY081100265 T CY 081100265T CY 1107298 T1 CY1107298 T1 CY 1107298T1
Authority
CY
Cyprus
Prior art keywords
meloxicam
water soluble
soluble granules
sweetener
relates
Prior art date
Application number
CY20081100265T
Other languages
Greek (el)
English (en)
Inventor
Martin Andreas Folger
Stefan Henke
Jens Schmalz
Diana Christine Keilhofer
Hans-Jürgen Kroff
Nina Herz
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of CY1107298T1 publication Critical patent/CY1107298T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Plant Substances (AREA)
CY20081100265T 2002-10-25 2008-03-07 Υδατοδιαλυτα κοκκια μελοξικαμης CY1107298T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10250081A DE10250081A1 (de) 2002-10-25 2002-10-25 Wasserlösliche Meloxicam Granulate
EP03809321A EP1558262B1 (de) 2002-10-25 2003-10-24 Wasserlösliche meloxicam granulate

Publications (1)

Publication Number Publication Date
CY1107298T1 true CY1107298T1 (el) 2012-11-21

Family

ID=32103087

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100265T CY1107298T1 (el) 2002-10-25 2008-03-07 Υδατοδιαλυτα κοκκια μελοξικαμης

Country Status (27)

Country Link
US (1) US20130005714A1 (https=)
EP (1) EP1558262B1 (https=)
JP (2) JP4856377B2 (https=)
KR (1) KR101152689B1 (https=)
CN (1) CN1708307B (https=)
AR (1) AR041717A1 (https=)
AT (1) ATE381337T1 (https=)
AU (1) AU2003276170B2 (https=)
BR (1) BR0315639A (https=)
CA (1) CA2503396C (https=)
CO (1) CO5570680A2 (https=)
CY (1) CY1107298T1 (https=)
DE (2) DE10250081A1 (https=)
DK (1) DK1558262T3 (https=)
ES (1) ES2298619T3 (https=)
HR (1) HRP20050366B1 (https=)
MX (1) MXPA05004211A (https=)
MY (1) MY136901A (https=)
PE (1) PE20040495A1 (https=)
PL (1) PL212425B1 (https=)
PT (1) PT1558262E (https=)
RU (1) RU2333744C2 (https=)
TW (1) TWI336622B (https=)
UA (1) UA81785C2 (https=)
UY (1) UY28039A1 (https=)
WO (1) WO2004037264A1 (https=)
ZA (1) ZA200502702B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
CN1680427B (zh) * 2005-02-01 2010-08-11 杨喜鸿 易于水溶解的匹多莫德复盐及其制备方法
WO2007011349A1 (en) * 2005-07-15 2007-01-25 Teva Pharmaceutical Industries Ltd. Novel granulation process and granulate produced therefrom
AU2006298895B9 (en) * 2005-09-30 2013-01-24 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
US7572641B2 (en) 2005-11-22 2009-08-11 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions comprising meloxicam and methods of their preparation
US7772255B2 (en) * 2005-12-13 2010-08-10 Supratek Pharma, Inc. Method of treating tumors with azaxanthones
KR100791160B1 (ko) * 2006-05-30 2008-01-02 조선대학교산학협력단 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물
JP2010083826A (ja) * 2008-10-01 2010-04-15 Nihon Generic Co Ltd オキシカム系化合物を含む固形製剤を製造する方法
TR200809200A1 (tr) * 2008-12-01 2009-12-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Meloksikam içeren farmasötik formülasyonlar
MX389960B (es) 2009-10-12 2025-03-20 Boehringer Ingelheim Vetmedica Gmbh Recipientes para composiciones que comprenden meloxicam.
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
RU2465892C1 (ru) * 2011-09-21 2012-11-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Новосибирский национальный исследовательский государственный университет (НГУ)" Способ получения высокодисперсного мелоксикама
CN103705479B (zh) * 2012-09-29 2017-11-28 瑞普(天津)生物药业有限公司 一种宠物用美洛昔康缓释片及其制备方法
RU2559000C1 (ru) * 2014-02-25 2015-08-10 Вячеслав Михайлович Спиридонов Кормовая добавка бфк
US9526734B2 (en) * 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
WO2016086114A1 (en) * 2014-11-25 2016-06-02 Artdem, Llc Sports drink formulation
US20170281640A1 (en) * 2016-04-04 2017-10-05 Productos Maver, S.A. De C.V. Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID)
EP3541815A4 (en) 2016-11-18 2020-07-15 Pacira Pharmaceuticals, Inc. ZINC MELXICAM COMPLEX MICROPARTICLE MULTIVESICULAR LIPOSOME FORMULATIONS AND METHODS OF MAKING THE SAME
JP2019163249A (ja) * 2018-03-16 2019-09-26 フジタ製薬株式会社 メロキシカム水性溶液

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102416A (en) * 1976-02-19 1977-08-27 Okawara Mfg Granule making method of herb medicine and like
DE3218150C2 (de) * 1982-05-14 1986-09-25 Akzo Gmbh, 5600 Wuppertal Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung
JPH0753663B2 (ja) * 1984-10-09 1995-06-07 武田薬品工業株式会社 チアミン塩の顆粒,その製造法および錠剤
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
JPH0912426A (ja) * 1995-06-29 1997-01-14 Asahi Chem Ind Co Ltd 吸湿性物質組成物
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
US6106862A (en) * 1998-08-13 2000-08-22 Andrx Corporation Once daily analgesic tablet
DE19859636A1 (de) * 1998-12-23 2000-06-29 Hexal Ag Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff
US6685928B2 (en) * 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
WO2001097812A1 (fr) * 2000-06-20 2001-12-27 Fujisawa Pharmaceutical Co., Ltd. Preparations pharmaceutiques contenant des composes tetracycliques
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate

Also Published As

Publication number Publication date
DK1558262T3 (da) 2008-01-28
EP1558262A1 (de) 2005-08-03
ATE381337T1 (de) 2008-01-15
ES2298619T3 (es) 2008-05-16
EP1558262B1 (de) 2007-12-19
KR101152689B1 (ko) 2012-06-15
DE10250081A1 (de) 2004-05-13
MY136901A (en) 2008-11-28
BR0315639A (pt) 2005-08-30
JP2011213726A (ja) 2011-10-27
AR041717A1 (es) 2005-05-26
CA2503396C (en) 2011-12-13
AU2003276170B2 (en) 2009-07-16
ZA200502702B (en) 2008-01-30
PL375479A1 (en) 2005-11-28
HRP20050366A2 (en) 2006-06-30
CN1708307B (zh) 2011-12-07
HK1084878A1 (en) 2006-08-11
US20130005714A1 (en) 2013-01-03
DE50308863D1 (de) 2008-01-31
CA2503396A1 (en) 2004-05-06
UY28039A1 (es) 2004-05-31
HRP20050366B1 (hr) 2013-12-06
UA81785C2 (uk) 2008-02-11
TWI336622B (en) 2011-02-01
CO5570680A2 (es) 2005-10-31
AU2003276170A1 (en) 2004-05-13
PE20040495A1 (es) 2004-09-17
PT1558262E (pt) 2008-01-18
KR20050070079A (ko) 2005-07-05
MXPA05004211A (es) 2005-06-08
JP5579132B2 (ja) 2014-08-27
TW200501961A (en) 2005-01-16
JP2006505574A (ja) 2006-02-16
RU2333744C2 (ru) 2008-09-20
CN1708307A (zh) 2005-12-14
JP4856377B2 (ja) 2012-01-18
RU2005115955A (ru) 2006-02-10
WO2004037264A1 (de) 2004-05-06
PL212425B1 (pl) 2012-09-28

Similar Documents

Publication Publication Date Title
CY1107298T1 (el) Υδατοδιαλυτα κοκκια μελοξικαμης
CY1107084T1 (el) Παραγωγα πυρρολοπυριδαζινης
CY1123050T1 (el) Φαρμακα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
CY1106801T1 (el) Νεες ετεροκυκλικες ενωσεις, η παρασκευη τους και η χρηση τους ως φαρμακα, ιδιαιτερα ως αντιβακτηριακα
CY1120994T1 (el) Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων
CY1117656T1 (el) Επιλογες θεραπειας για τη νοσο του fabry
CY1106589T1 (el) (s)-2-ν-προπυλαμινο-5-υδροξυτετραλινη ως d3-αγωνιστικο θεραπευτικο μεσο
CY1105362T1 (el) Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
CY1106634T1 (el) Θεραπευτικα παραγωγα της πιπεραζινης
CY1106679T1 (el) Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
CY1119481T1 (el) Εισπνευσιμη επινεφρινη
CY1106693T1 (el) Πελετες οι οποιες περιεχουν υδροχλωρικη βενλαφαξινη
CY1108067T1 (el) Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης
ATE316077T1 (de) Pyrimidin-essigsäure derivate geeignet zur behandlung von crth2-bedingten krankheiten
CY1110332T1 (el) Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους
PE20061397A1 (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos productos y metodos de preparacion
CY1107633T1 (el) Υδατικο φαρμακευτικο διαλυμα περιεχον οξυμεταζολινη και/ή ξυλομεταζολινη
CY1115719T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
CY1105091T1 (el) Αντικατεστημενες ενωσεις 2-αρυλοβενζαζολιου και η χρηση τους σαν παραγοντες κατα των ογκων
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1109120T1 (el) Φαρμακευτικη συνθεση βινφλουνινης που προοριζεται για παρεντερικη χορηγηση, μεθοδος παρασκευης και χρησης
CY1115407T1 (el) Θοριο-227 για χρηση στην ακτινοθεραπεια ασθενειων των μαλακων ιστων
CY1109376T1 (el) Παραγωγα υδαντοϊνης χρησιμα ως αναστολεις μεταλλοπρωτεϊνασης
CY1107985T1 (el) Ccr1 ανταγωνιστες για την αγωγη μεταξυ αλλων απομυελινωτικης φλεγμονωδους νοσου